News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
645,923 Results
Type
Article (61385)
Company Profile (71)
Press Release (584467)
Multimedia
Podcasts (62)
Webinars (13)
Section
Business (173742)
Career Advice (2734)
Deals (32426)
Drug Delivery (99)
Drug Development (76855)
Employer Resources (150)
FDA (14942)
Job Trends (13894)
News (304968)
Policy (28998)
Tag
Academia (2894)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (90)
Alliances (43173)
ALS (92)
Alzheimer's disease (1325)
Antibody-drug conjugate (ADC) (116)
Approvals (14952)
Artificial intelligence (272)
Autoimmune disease (24)
Automation (15)
Bankruptcy (290)
Best Places to Work (10859)
BIOSECURE Act (16)
Biosimilars (102)
Biotechnology (53)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (285)
Cancer (2230)
Cardiovascular disease (169)
Career advice (2316)
Career pathing (33)
CAR-T (157)
Cell therapy (440)
Cervical cancer (21)
Clinical research (62572)
Collaboration (808)
Company closure (2)
Compensation (342)
Complete response letters (20)
COVID-19 (2575)
CRISPR (45)
C-suite (270)
Cystic fibrosis (102)
Data (2244)
Decentralized trials (2)
Denatured (26)
Depression (45)
Diabetes (258)
Diagnostics (6167)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (113)
Drug pricing (104)
Drug shortages (23)
Duchenne muscular dystrophy (89)
Earnings (60408)
Editorial (41)
Employer branding (18)
Employer resources (132)
Events (94653)
Executive appointments (774)
FDA (16296)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (765)
Gene editing (114)
Generative AI (20)
Gene therapy (307)
GLP-1 (674)
Government (4477)
Grass and pollen (6)
Guidances (146)
Healthcare (18222)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (112)
Indications (28)
Infectious disease (2711)
Inflammatory bowel disease (142)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (97)
Interviews (527)
IPO (14800)
IRA (40)
Job creations (3417)
Job search strategy (1944)
Kidney cancer (10)
Labor market (34)
Layoffs (512)
Leadership (22)
Legal (6472)
Liver cancer (70)
Lung cancer (308)
Lymphoma (147)
Machine learning (9)
Management (53)
Manufacturing (292)
MASH (69)
Medical device (12662)
Medtech (12667)
Mergers & acquisitions (18227)
Metabolic disorders (653)
Multiple sclerosis (79)
NASH (13)
Neurodegenerative disease (85)
Neuropsychiatric disorders (26)
Neuroscience (1853)
NextGen: Class of 2025 (6382)
Non-profit (4321)
Now hiring (13)
Obesity (332)
Opinion (232)
Ovarian cancer (76)
Pain (96)
Pancreatic cancer (84)
Parkinson's disease (143)
Partnered (21)
Patents (243)
Patient recruitment (115)
Peanut (50)
People (59628)
Pharmaceutical (20)
Pharmacy benefit managers (16)
Phase I (19686)
Phase II (27613)
Phase III (20165)
Pipeline (1280)
Policy (136)
Postmarket research (2472)
Preclinical (8408)
Press Release (67)
Prostate cancer (108)
Psychedelics (27)
Radiopharmaceuticals (249)
Rare diseases (367)
Real estate (5989)
Recruiting (61)
Regulatory (20148)
Reports (34)
Research institute (2396)
Resumes & cover letters (406)
Rett syndrome (5)
RNA editing (3)
RSV (35)
Schizophrenia (71)
Series A (132)
Series B (90)
Service/supplier (9)
Sickle cell disease (52)
Special edition (12)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3354)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (31)
The Weekly (34)
Vaccines (673)
Venture capitalists (35)
Weight loss (207)
Women's health (31)
Worklife (19)
Date
Today (34)
Last 7 days (888)
Last 30 days (2845)
Last 365 days (30216)
2025 (11046)
2024 (32290)
2023 (36352)
2022 (46638)
2021 (51597)
2020 (50749)
2019 (44797)
2018 (34092)
2017 (30747)
2016 (30095)
2015 (35487)
2014 (28417)
2013 (24970)
2012 (26239)
2011 (26492)
2010 (24963)
Location
Africa (871)
Alabama (55)
Alaska (6)
Arizona (171)
Arkansas (14)
Asia (38103)
Australia (6862)
California (5777)
Canada (1890)
China (496)
Colorado (253)
Connecticut (263)
Delaware (148)
Europe (88827)
Florida (879)
Georgia (205)
Idaho (56)
Illinois (559)
India (25)
Indiana (285)
Iowa (10)
Japan (162)
Kansas (97)
Kentucky (24)
Louisiana (11)
Maine (61)
Maryland (851)
Massachusetts (4165)
Michigan (226)
Minnesota (348)
Mississippi (2)
Missouri (88)
Montana (29)
Nebraska (23)
Nevada (61)
New Hampshire (61)
New Jersey (1694)
New Mexico (29)
New York (1680)
North Carolina (975)
North Dakota (9)
Northern California (2524)
Ohio (198)
Oklahoma (15)
Oregon (36)
Pennsylvania (1275)
Puerto Rico (13)
Rhode Island (31)
South America (1177)
South Carolina (19)
South Dakota (1)
Southern California (2210)
Tennessee (99)
Texas (881)
United States (21937)
Utah (180)
Virginia (147)
Washington D.C. (52)
Washington State (521)
West Virginia (3)
Wisconsin (62)
645,923 Results for "university of bern".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Artelo Biosciences to Present its New Data on ART12.11 Tablets Compared to Epidiolex at the IMCCB-25 Conference in Bern, Switzerland
February 11, 2025
·
4 min read
Editorial
Lilly Is Not ‘Feeling the Bern’ on Drug Prices Like Novo: Why the Double Standard?
Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s rival drugs, is not fair.
September 27, 2024
·
3 min read
·
Greg Slabodkin
Business
Faron Appoints Dr. Birge Berns, MD as Interim Chief Medical Officer
Faron Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, announces the appointment of Dr. Birge Berns, MD, as the Company’s interim Chief Medical Officer.
September 21, 2023
·
6 min read
Diabetes Center Berne Selects XtremedX Diabetic Shoe Insole as Top 20 New Diabetic Device for 2022
A revolutionary temperature and pressure (TAP) sensing insole for diabetics, created by XtremedX, was recently named a TOP 20 New Diabetic Device for 2022 by the Diabetes Center Berne (DCB) in Berne, Switzerland.
May 24, 2022
·
3 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Business
Asensus Surgical Announces Inselspital University Hospital in Bern, Switzerland to start Senhance Surgery
Asensus Surgical , Inc. today announced Inselspital, University Hospital Bern, Switzerland has initiated its Senhance® Surgical System program.
June 28, 2021
·
3 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Policy
LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready Robotic System for FDA Submission
LEM Surgical AG, an innovative surgical robotics company headquartered in Bern, Switzerland, announces the successful completion of its Series B funding, securing CHF 22 million.
January 4, 2024
·
1 min read
Drug Development
Eroding Immunity: Vaccine Hesitancy and Cynicism With Paul Offit
In this episode of Denatured BioSpace’s head of insights Lori Ellis discusses the public health consequences of vaccine hesitancy and the critical distinction between skepticism and cynicism with Paul Offit, MD, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia.
May 8, 2025
·
1 min read
·
Lori Ellis
Press Releases
LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland
April 28, 2025
·
4 min read
1 of 64,593
Next
